Catalog name Description price
R-C-5766 PLGA10000-PEG3400-[GPO]7-NH2 PLGA-PEG-[GPO]7-NH2,[GPO]7 is a peptide sequence that consists of the amino acids glycine (G) and proline (P) repeated seven times. This sequence forms a stable triple helix structure known as a collagen-like peptide. Collagen is a major component of the extracellular matrix and plays a crucial role in various biological processes, including cell adhesion and tissue repair.PLGA confers biodegradability and controlled drug release properties,PEG enhances biocompatibility and circulation time.This combination is particularly useful in drug delivery systems,tissue engineering, and regenerative medicine applications. price>
R-C-5767 PLGA10000-PEG3400-TRYLRHPQSQVHQI-NH2 PLGA-PEG-TRYLRHPQSQVHQI-NH2,PLGA-PEG-NH2 is a functional amphiphilic block copolymer (ABC) which has amine group at the end of PEG block and is used to prepare nanoparticles and micelles for targeted drug delivery.PLGA-PEG is one of the most commonly used biodegradable ABC polymers for drug delivery.The PEG end can be connected to functional groups such as peptides, such as TRYLRHPQSQVHQI. price>
R-C-5774 PEG550-PLGA2810-PEG550 75:25 The PEG segments can provide a protective shell around the PLGA core, reducing protein adsorption and opsonization, thus improving the circulation time and reducing clearance by the immune system. Additionally, other functional groups or moieties can be incorporated into the PEG-PLGA-PEG structure for further tuning of properties or specific conjugation with therapeutic agents. price>
R-C-5777 PDMA2K-PLGA5K PLGA-b-PDMA,PDMA-PLGA,PLGA-b-PDMA because PDMA by itself is a potent polycation used in nonviral gene delivery,and PLGA provides the hydrophobic core to form cNP.The binding of NA to cNP stems from charge interaction and we could optimize the NA-scavenging performance of the cNP by varying the molecular weight of PDMA.This product is only used for scientific research experiments and is not intended for clinical human use. price>
R-C-5784 PLGA5000-b-PEOz2000-NHS PLGA-b-PEOz-NHS,PLGA-PEOz-NHS,PLGA-PEOz-NHS is an amphiphilic AB diblock copolymer composed of hydrophilic PEOz and hydrophobic poly(D,L-lactide co glycolide).PEOz polymers are capped by active esters and can react with other reactive chemical groups such as amino modified proteins,peptides,and other materials.PEOz can completely replace PEG polyethylene glycol as a drug carrier material and can be used to prepare pH responsive nanoparticles for drug delivery. price>
R-C-5790 PLGA5k-TK-amino acid PLGA-TK-amino acid refers to a composite material formed by combining PLGA (poly(lactic-co-glycolic acid)) with a specific amino acid sequence that contains a thymidine kinase (TK) domain.It is commonly used in drug delivery systems, tissue engineering, and other biomedical applications due to its controlled release capabilities and compatibility with living organisms. price>
R-C-5793 PLGA15K-P1-PEG5K PLGA is a biodegradable polymer that has been widely utilized in the pharmaceutical field due to its excellent biocompatibility and controlled release properties. PEG is added to enhance the hydrophilicity and stability of the copolymer.The PEGylation pattern P1 refers to the specific design and arrangement of PEG molecules along the PLGA backbone.Different PEGylation patterns can affect the properties and performance of the copolymer,including drug loading,release kinetics,and biodistribution. price>
R-C-5820 PLGA5000-SS-PEI1800 PLGA-SS-PEI,PEI-SS-PLGA,Poly(lactic-co-glycolic acid) (PLGA) is a biodegradable and biocompatible polymer commonly used in drug delivery systems and tissue engineering.PLGA offers control over drug release kinetics and can degrade into non-toxic byproducts in the body.The disulfide-containing linker (SS) refers to a chemical group containing a disulfide bond (-SS-).Polyethylenimine (PEI) is a cationic polymer that can complex with DNA, RNA, or other negatively charged molecules, making it suitable for gene delivery applications. PEI can condense nucleic acids into nanoparticles and facilitate their cellular uptake and release into the cell nucleus. price>
R-C-5822 PLGA10k-Se-Se-PLGA10k 50:50 PLGA-Se-Se-PLGA,PLGA with diselenide-containing linkers,the resulting PLGA-Se-Se-PLGA copolymer can possess controlled drug release properties.The incorporation of diselenide bonds enables the degradation of the copolymer in the presence of reducing agents, such as glutathione,found abundantly inside cells.This behavior allows for the controlled release of encapsulated drugs at targeted sites or within specific cells. price>
R-C-5823 PLGA-PEI-PEG-COOH PLGA 36 kDa PEI:25 kDa PEG:2 kDa PLGA-PEI-PEG-COOH copolymer provides a multifunctional platform for drug delivery and gene delivery applications. The PLGA component can encapsulate hydrophobic drugs and enable their sustained release. The presence of PEI facilitates the condensation and protection of nucleic acids for gene delivery. PEG enhances the stability and biocompatibility of the copolymer, while the carboxylic acid groups allow for additional functionalization or conjugation with desired molecules. price>